Automated Sample Preparation Platform for Mass Spectrometry-Based Plasma Proteomics and Biomarker Discovery
暂无分享,去创建一个
Hanno Langen | Axel Ducret | Paul Cutler | Jens Lamerz | P. Cutler | H. Langen | P. Piraino | A. Ducret | J. Lamerz | Vilém Guryča | Daniel Roeder | Paolo Piraino | V. Guryča | D. Roeder
[1] Pei Wang,et al. A targeted proteomics–based pipeline for verification of biomarkers in plasma , 2011, Nature Biotechnology.
[2] N. Zolotarjova,et al. Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum. , 2008, Journal of chromatography. A.
[3] C. Lenz,et al. Multiple reaction monitoring cubed for protein quantification at the low nanogram/milliliter level in nondepleted human serum. , 2009, Analytical chemistry.
[4] H. Gendelman,et al. Multidimensional protein fractionation using ProteomeLab PF 2D™ for profiling amyotrophic lateral sclerosis immunity: A preliminary report , 2008, Proteome Science.
[5] Z. El Rassi,et al. Micro‐high‐performance liquid chromatography platform for the depletion of high‐abundance proteins and subsequent on‐line concentration/capturing of medium and low‐abundance proteins from serum. Application to profiling of protein expression in healthy and osteoarthritis sera by 2‐D gel electrophore , 2008, Electrophoresis.
[6] Amy-Joan L Ham,et al. Sample preparation and digestion for proteomic analyses using spin filters , 2005, Proteomics.
[7] Pingbo Zhang,et al. Multiplex assays for biomarker research and clinical application: Translational science coming of age , 2010, Proteomics. Clinical applications.
[8] Z. El Rassi,et al. Multicolumn separation platform for simultaneous depletion and prefractionation prior to 2-DE for facilitating in-depth serum proteomics profiling. , 2009, Journal of proteome research.
[9] Christoph H Borchers,et al. A Human Proteome Detection and Quantitation Project* , 2009, Molecular & Cellular Proteomics.
[10] Derek J. Bailey,et al. Parallel Reaction Monitoring for High Resolution and High Mass Accuracy Quantitative, Targeted Proteomics* , 2012, Molecular & Cellular Proteomics.
[11] A. Emili,et al. High‐resolution biomarker discovery: Moving from large‐scale proteome profiling to quantitative validation of lead candidates , 2008, Proteomics. Clinical applications.
[12] David T. Kaleta,et al. Enhanced Detection of Low Abundance Human Plasma Proteins Using a Tandem IgY12-SuperMix Immunoaffinity Separation Strategy*S , 2008, Molecular & Cellular Proteomics.
[13] A. Salvador,et al. Clinical Quantitation of Prostate-specific Antigen Biomarker in the Low Nanogram/Milliliter Range by Conventional Bore Liquid Chromatography-Tandem Mass Spectrometry (Multiple Reaction Monitoring) Coupling and Correlation with ELISA Tests , 2009, Molecular & Cellular Proteomics.
[14] Eugene A. Kapp,et al. Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database , 2005, Proteomics.
[15] Kelly A. Jones,et al. Immunodepletion plasma proteomics by tripleTOF 5600 and Orbitrap elite/LTQ-Orbitrap Velos/Q exactive mass spectrometers. , 2013, Journal of proteome research.
[16] Damon H. May,et al. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. , 2011, Journal of proteome research.
[17] P. Cutler,et al. Qualitative improvement and quantitative assessment of N‐terminomics , 2012, Proteomics.
[18] N. Anderson,et al. The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. , 2010, Clinical chemistry.
[19] Xu Shi,et al. Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution* , 2009, Molecular & Cellular Proteomics.
[20] Kai Pong Law,et al. Recent advances in mass spectrometry: data independent analysis and hyper reaction monitoring , 2013, Expert review of proteomics.
[21] Nicholas A. Cellar,et al. Immunodepletion of high abundance proteins coupled on-line with reversed-phase liquid chromatography: a two-dimensional LC sample enrichment and fractionation technique for mammalian proteomics. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[22] C. Eyers. Universal sample preparation method for proteome analysis , 2009 .
[23] Gary Siuzdak,et al. Sepsis plasma protein profiling with immunodepletion, three-dimensional liquid chromatography tandem mass spectrometry, and spectrum counting. , 2006, Journal of proteome research.
[24] H. Langen,et al. Depletion of the high-abundance plasma proteins , 2004, Amino Acids.
[25] G. Nicol,et al. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins. , 2005, Journal of proteome research.
[26] S. Hanash. A call for a fresh new look at the plasma proteome , 2012, Proteomics. Clinical applications.
[27] R. Aebersold,et al. Applying mass spectrometry-based proteomics to genetics, genomics and network biology , 2009, Nature Reviews Genetics.
[28] Richard D. Smith,et al. Advancing the sensitivity of selected reaction monitoring‐based targeted quantitative proteomics , 2012, Proteomics.
[29] Aditi Chatterjee,et al. Plasma Proteome Database as a resource for proteomics research: 2014 update , 2013, Nucleic Acids Res..
[30] B. Domon,et al. Targeted Proteomic Quantification on Quadrupole-Orbitrap Mass Spectrometer* , 2012, Molecular & Cellular Proteomics.